UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056821
Receipt number R000062356
Scientific Title Effects of Short-Term, Low-Intensity Exercise Instruction on Physical Activity in Patients With Advanced Lung Cancer -A Randomized Controlled Trial-
Date of disclosure of the study information 2025/01/27
Last modified on 2025/01/26 16:33:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of short-term, low-intensity exercise guidance on physical activity in patients with advanced lung cancer

Acronym

Effects of short-term, low-intensity exercise guidance on physical activity in patients with advanced lung cancer

Scientific Title

Effects of Short-Term, Low-Intensity Exercise Instruction on Physical Activity in Patients With Advanced Lung Cancer -A Randomized Controlled Trial-

Scientific Title:Acronym

Effects of Short-Term, Low-Intensity Exercise Instruction on Physical Activity in Patients With Advanced Lung Cancer -A Randomized Controlled Trial-

Region

Japan


Condition

Condition

Advanced lung cancer

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Effects of low-intensity, short-duration exercise guidance during hospitalization on physical activity, self-efficacy, and motor function after discharge from the hospital for patients with advanced lung cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Amount of physical activity.
Self-efficacy scale for advanced cancer.
The European Organization for Research and Treatment of Cancer.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

3 times at the time of hospitalization, discharge, and readmission

Interventions/Control_2

With or without intervention

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

95 years-old >

Gender

Male and Female

Key inclusion criteria

Stage 3~4 lung cancer patients undergoing chemotherapy
Patients with a PS of 2~3 who are able to walk independently
Patients who have received more than 2 courses of similar chemotherapy in hospital

Key exclusion criteria

Patients suspected of impaired consciousness or delirium
Patients with difficulty walking
Patients with cognitive function

Target sample size

30


Research contact person

Name of lead principal investigator

1st name junichi
Middle name
Last name yabuuchi

Organization

Fukuchiyama City Hospital

Division name

Department of Rehabilitation

Zip code

6200056

Address

231 Atsunaka-cho, Fukuchiyama-shi, Kyoto

TEL

0773222101

Email

saitoutakashi0214@yahoo.co.jp


Public contact

Name of contact person

1st name Junichi
Middle name
Last name yabuuchi

Organization

Fukuchiyama City Hospital

Division name

Department of Rehabilitation

Zip code

6200056

Address

231 Atsunaka-cho, Fukuchiyama-shi, Kyoto

TEL

0773222101

Homepage URL


Email

saitoutakashi0214@yahoo.co.jp


Sponsor or person

Institute

Fukuchiyama City Hospital

Institute

Department

Personal name

Department of Rehabilitation


Funding Source

Organization

Fukuchiyama City Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuchiyama City Hospital

Address

231 Atsunaka-cho, Fukuchiyama-shi, Kyoto

Tel

0773222101

Email

saitoutakashi0214@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 01 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

40

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 06 Month 10 Day

Date of IRB

2023 Year 06 Month 19 Day

Anticipated trial start date

2024 Year 06 Month 20 Day

Last follow-up date

2024 Year 06 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 01 Month 26 Day

Last modified on

2025 Year 01 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062356